Pre-Alzheimer’s Study
Advancing Health and Medicine Through Clinical Research Trials
With our latest clinical trials and comprehensive medical research, we aim to help people experiencing mild cognitive impairment or before symptoms of Alzheimer’s Disease start progressing.
What Is a Pre-Alzheimer's Study?
Some patients will be treated with medicines that have already been approved by the FDA for mild cognitive impairment or early Alzheimer’s Disease. Cognitive functions will be monitored periodically by a researcher. Additionally, they will take blood samples, perform other testing and imaging, including MRIs and possible PET scans to follow the progress.
Learn more about the Pre-Alzheimer's study designed to stop or at least slow the progression mild cognitive impairment and Alzheimer’s Disease.
Alzheimer’s Disease is a progressive condition that weakens memory and other mental abilities. During the early stages of Alzheimer’s disease, common changes include frequent forgetfulness, difficulty with language, and trouble making plans or organizing. No cure exists, but current medications may temporarily help with your symptoms.
Eligible participants will receive the study drug and close care and monitoring by an Alzheimer’s disease specialist at no cost. Reimbursement is available for study-related time and travel expenses.
Join One of Our Pre-Alzheimer’s Studies!
At Bradenton Research Center, we are working with companies attempting to stop or at least delay the progression of Alzheimer’s disease.
Even if you aren’t dealing with bad memory loss, this study may be right for you.
Participating in studies is voluntary, and all medical attention, care, and treatment are provided without additional cost. Contact us today
Pre-Alzheimer’s Studies
The primary objective of these studies is to evaluate the efficacy and safety of new medicines on patients with elevated pTau. By taking part in this study, you can help find the treatment that will hopefully stop or at least slow Alzheimer’s progression.
- Participants must:
- Be between 50 and 90 years of age
- Consent to APOE4/4 gene testing (provided at no cost)
- Have Mild Cognitive Impairment, Alzheimer’s Disease--we will evaluate on-site
Advantages of Participating in Pre-Alzheimer’s Studies
Detection of early Alzheimer’s is tough, and you might not experience symptoms before learning you have it. The disease has a number of early warning signs and symptoms, such as forgetting anniversaries, birthdays, or having trouble with a shopping list. If you are concerned about any of this, either because of family history, personal experience, or questionable memory issues, this study is for you!
Access to a new medicine
An Alzheimer's disease expert will provide close attention and supervision
Opportunity to advance Pre-Alzheimer's disease treatment
Reimbursement for travel and time spent on research activities
Participate in a study today!
Feel free to give us a call, fill out the form at the top of the page, email us or just stop by to chat.
Contact us today!